Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Lipid Metabolism and Multiple Sclerosis Severity: Genetic Evidence for a Causal Role of FADS1
Genetics
Lipid Metabolism and Multiple Sclerosis Severity: Genetic Evidence for a Causal Role of FADS1

22, Jul 2026

2
Lipid Metabolism and Multiple Sclerosis Severity: Genetic Evidence for a Causal Role of FADS1
Genetics
Rare Coding Variants and the Genetic Basis of Multiple Sclerosis

22, Jul 2026

3
Genetic Modulation of Lipid-Associated Disability Progression in Multiple Sclerosis
Genetics
Genetic Modulation of Lipid-Associated Disability Progression in Multiple Sclerosis

21, Jul 2026

4
Serotonin, Adenosine Metabolism and Multiple Sclerosis: A Multi-Omics Perspective
Genetics
Serotonin, Adenosine Metabolism and Multiple Sclerosis: A Multi-Omics Perspective

20, Jul 2026

5
Metabolic Drivers of Multiple Sclerosis: Insights from a Metabolome-Wide Mendelian Randomization Study
Genetics
Metabolic Drivers of Multiple Sclerosis: Insights from a Metabolome-Wide Mendelian Randomization Study

19, Jul 2026

Categories:
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025

Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?
Genetics
Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?

12, Jun 2025